Molecular analysis of the association of HLA-B53 and resistance to severe malaria
- PMID: 1280333
- DOI: 10.1038/360434a0
Molecular analysis of the association of HLA-B53 and resistance to severe malaria
Abstract
The protective association between the human leukocyte antigen HLA-B53 and severe malaria was investigated by sequencing of peptides eluted from this molecule followed by screening of candidate epitopes from pre-erythrocytic-stage antigens of Plasmodium falciparum in biochemical and cellular assays. Among malaria-immune Africans, HLA-B53-restricted cytotoxic T lymphocytes recognized a conserved nonamer peptide from liver-stage-specific antigen-1 (LSA-1), but no HLA-B53-restricted epitopes were identified in other antigens. These findings indicate a possible molecular basis for this HLA-disease association and support the candidacy of liver-stage-specific antigen-1 as a malaria vaccine component.
Comment in
-
Malaria. Another route to a vaccine?Nature. 1992 Dec 3;360(6403):417-8. doi: 10.1038/360417a0. Nature. 1992. PMID: 1360149 No abstract available.
Similar articles
-
Cytotoxic T-lymphocyte epitopes for HLA-B53 and other HLA types in the malaria vaccine candidate liver-stage antigen 3.Infect Immun. 2000 Jan;68(1):227-32. doi: 10.1128/IAI.68.1.227-232.2000. Infect Immun. 2000. PMID: 10603392 Free PMC article.
-
Cytotoxic T lymphocytes to Plasmodium falciparum epitopes in an area of intense and perennial transmission in Tanzania.Eur J Immunol. 1996 Apr;26(4):773-9. doi: 10.1002/eji.1830260408. Eur J Immunol. 1996. PMID: 8625967
-
Plasmodium falciparum liver stage antigen-1 is well conserved and contains potent B and T cell determinants.J Immunol. 1994 Jul 1;153(1):190-204. J Immunol. 1994. PMID: 7515922
-
Pre-erythrocytic malaria vaccine: mechanisms of protective immunity and human vaccine trials.Parassitologia. 1999 Sep;41(1-3):397-402. Parassitologia. 1999. PMID: 10697892 Review.
-
An HLA-based approach to the design of a CTL-inducing vaccine against Plasmodium falciparum.Res Immunol. 1994 Jul-Aug;145(6):461-8. doi: 10.1016/s0923-2494(94)80177-0. Res Immunol. 1994. PMID: 7534937 Review. No abstract available.
Cited by
-
The effect of host heterogeneity and parasite intragenomic interactions on parasite population structure.Proc Biol Sci. 2005 Aug 22;272(1573):1647-53. doi: 10.1098/rspb.2005.3134. Proc Biol Sci. 2005. PMID: 16087418 Free PMC article.
-
An adaptation of recombinant vaccinia-based ELISPOT and intracellular cytokine staining for a comparative measurement of cellular immune responses in HIV-1 and HIV-2 infections in West Africa.Clin Exp Immunol. 2006 Dec;146(3):471-8. doi: 10.1111/j.1365-2249.2006.03238.x. Clin Exp Immunol. 2006. PMID: 17100767 Free PMC article.
-
Falciparum malaria selected while HIV-1 slaughtered.Indian J Hum Genet. 2008 May;14(2):70. doi: 10.4103/0971-6866.44109. Indian J Hum Genet. 2008. PMID: 20300298 Free PMC article. No abstract available.
-
Natural killer T cell ligand alpha-galactosylceramide enhances protective immunity induced by malaria vaccines.J Exp Med. 2002 Mar 4;195(5):617-24. doi: 10.1084/jem.20011889. J Exp Med. 2002. PMID: 11877484 Free PMC article.
-
HLA/KIR restraint of HIV: surviving the fittest.Annu Rev Immunol. 2011;29:295-317. doi: 10.1146/annurev-immunol-031210-101332. Annu Rev Immunol. 2011. PMID: 21219175 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials